424 related articles for article (PubMed ID: 6592388)
1. Pharmacologic and genetic studies on the modulatory effects of butylated hydroxytoluene on mouse lung adenoma formation.
Malkinson AM; Beer DS
J Natl Cancer Inst; 1984 Oct; 73(4):925-33. PubMed ID: 6592388
[TBL] [Abstract][Full Text] [Related]
2. Effects of strain and age on prophylaxis and co-carcinogenesis of urethan-induced mouse lung adenomas by butylated hydroxytoluene.
Malkinson AM; Thaete LG
Cancer Res; 1986 Apr; 46(4 Pt 1):1694-7. PubMed ID: 3948160
[TBL] [Abstract][Full Text] [Related]
3. Decrease in the protein kinase C-catalyzed phosphorylation of an endogenous lung protein (Mr 36,000) following treatment of mice with the tumor-modulatory agent butylated hydroxytoluene.
Malkinson AM; Beer DS; Sadler AJ; Coffman DS
Cancer Res; 1985 Nov; 45(11 Pt 2):5751-6. PubMed ID: 4053047
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the incidence of urethane induced mouse lung adenomas by butylated hydroxytoluene (BHT).
Malkinson AM
Proc West Pharmacol Soc; 1983; 26():417-9. PubMed ID: 6889373
[No Abstract] [Full Text] [Related]
5. Separation of early diffuse alveolar cell proliferation from enhanced tumor development in mouse lung.
Witschi HP
Cancer Res; 1986 Jun; 46(6):2675-9. PubMed ID: 3698002
[TBL] [Abstract][Full Text] [Related]
6. Major effect on susceptibility to urethan-induced pulmonary adenoma by a single gene in BALB/cBy mice.
Malkinson AM; Beer DS
J Natl Cancer Inst; 1983 May; 70(5):931-6. PubMed ID: 6573537
[TBL] [Abstract][Full Text] [Related]
7. Genetic influence on type 2 or Clara cell origin of pulmonary adenomas in urethan-treated mice.
Beer DG; Malkinson AM
J Natl Cancer Inst; 1985 Nov; 75(5):963-9. PubMed ID: 3863993
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of lung tumor formation in mice by dietary butylated hydroxytoluene: dose-time relationships and cell kinetics.
Witschi HR; Morse CC
J Natl Cancer Inst; 1983 Oct; 71(4):859-66. PubMed ID: 6578375
[TBL] [Abstract][Full Text] [Related]
9. Changes in pulmonary adenosine triphosphate-binding proteins detected by nucleotide photoaffinity labeling following treatment of mice with the tumor-modulatory agent butylated hydroxytoluene.
Malkinson AM; Haley BE; Macintyre BE; Butley MS
Cancer Res; 1986 Sep; 46(9):4626-30. PubMed ID: 3731115
[TBL] [Abstract][Full Text] [Related]
10. Butylated hydroxytoluene exposure is necessary to induce lung tumors in BALB mice treated with 3-methylcholanthrene.
Malkinson AM; Koski KM; Evans WA; Festing MF
Cancer Res; 1997 Jul; 57(14):2832-4. PubMed ID: 9230183
[TBL] [Abstract][Full Text] [Related]
11. Protein damage from electrophiles and oxidants in lungs of mice chronically exposed to the tumor promoter butylated hydroxytoluene.
Shearn CT; Fritz KS; Thompson JA
Chem Biol Interact; 2011 Jul; 192(3):278-86. PubMed ID: 21536018
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in the proliferation of murine pulmonary type II cells: basal rates and alterations following urethan treatment.
Thaete LG; Beer DG; Malkinson AM
Cancer Res; 1986 Oct; 46(10):5335-8. PubMed ID: 3756882
[TBL] [Abstract][Full Text] [Related]
13. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice.
Thompson JA; Malkinson AM; Wand MD; Mastovich SL; Mead EW; Schullek KM; Laudenschlager WG
Drug Metab Dispos; 1987; 15(6):833-40. PubMed ID: 2893710
[TBL] [Abstract][Full Text] [Related]
14. Lung toxicity and tumor promotion by hydroxylated derivatives of 2,6-di-tert-butyl-4-methylphenol (BHT) and 2-tert-butyl-4-methyl-6-iso-propylphenol: correlation with quinone methide reactivity.
Kupfer R; Dwyer-Nield LD; Malkinson AM; Thompson JA
Chem Res Toxicol; 2002 Aug; 15(8):1106-12. PubMed ID: 12184795
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of urethan tumorigenesis in mouse lung by butylated hydroxytoluene.
Witschi H; Williamson D; Lock S
J Natl Cancer Inst; 1977 Feb; 58(2):301-5. PubMed ID: 833878
[TBL] [Abstract][Full Text] [Related]
16. Cellular derivation of lung tumors in sensitive and resistant strains of mice: results at 28 and 56 weeks after urethan treatment.
Thaete LG; Gunning WT; Stoner GD; Malkinson AM
J Natl Cancer Inst; 1987 Apr; 78(4):743-9. PubMed ID: 3470549
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activation of butylated hydroxytoluene by mouse bronchiolar Clara cells.
Bolton JL; Thompson JA; Allentoff AJ; Miley FB; Malkinson AM
Toxicol Appl Pharmacol; 1993 Nov; 123(1):43-9. PubMed ID: 8236260
[TBL] [Abstract][Full Text] [Related]
18. A metabolite of butylated hydroxytoluene with potent tumor-promoting activity in mouse lung.
Thompson JA; Schullek KM; Fernandez CA; Malkinson AM
Carcinogenesis; 1989 Apr; 10(4):773-5. PubMed ID: 2702725
[TBL] [Abstract][Full Text] [Related]
19. Strain-related differences in the pneumotoxic effects of chronically administered butylated hydroxytoluene on protein kinase C and calpain.
Miller AC; Dwyer LD; Auerbach CE; Miley FB; Dinsdale D; Malkinson AM
Toxicology; 1994 May; 90(1-2):141-59. PubMed ID: 8023339
[TBL] [Abstract][Full Text] [Related]
20. Carbonyl reductase inactivation may contribute to mouse lung tumor promotion by electrophilic metabolites of butylated hydroxytoluene: protein alkylation in vivo and in vitro.
Shearn CT; Fritz KS; Meier BW; Kirichenko OV; Thompson JA
Chem Res Toxicol; 2008 Aug; 21(8):1631-41. PubMed ID: 18597497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
